Axis Scores Docs In D&O Coverage Fight With BioChemics

Law360, New York (August 9, 2013, 3:59 PM EDT) -- Axis Reinsurance Co. will be able to delve into BioChemics Inc.'s communications with the U.S. Securities and Exchange Commission after a Massachusetts federal judge on Wednesday cleared the way for discovery in a suit over directors and officers coverage for an SEC enforcement action.

In her order, U.S. District Judge Rya Zobel held that Axis was entitled to discovery because the extrinsic evidence it sought was irrelevant to the merits of the SEC's enforcement action against BioChemics and John Masiz, its president and CEO.

She held...
To view the full article, register now.




Case Information

Case Title

Biochemics, Inc. v. Axis Reinsurance Company

Case Number




Nature of Suit



Rya W. Zobel

Date Filed

March 26, 2013

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.